Live Breaking News & Updates on Alzheimer Congress

Stay updated with breaking news from Alzheimer congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioVie: Cautiously Optimistic Ahead Of Phase 3 Alzheimer's Data Unblinding (NASDAQ:BIVI)

BioVie: Cautiously Optimistic Ahead Of Phase 3 Alzheimer's Data Unblinding (NASDAQ:BIVI)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United States , Donanemab Eli Lilly , Jesse Brodkin , Terren Peizer , Donepezil Aricept , Data Cassava Press , Cassava Press , Cassava Sciences , Anavex Life Sciences , Alzheimer Congress , Neurodegenerative Clinical Development , Company Overview , Office Of Scientific Integrity , Biovie Company Presentation , Harbor Therapeutics , Life Science Phase , Donanemab Phase , Eli Lilly , Even Donepezil , Blinded Data , Chief Strategy Officer , Failure To Communicate , Life Sciences ,

Why we are at a 'historic moment' in Alzheimer's research

IT is well over 100 years since Alois Alzheimer first described what he called an “unusual disease of the cerebral cortex”. ....

City Of , United Kingdom , United States , San Francisco , John Hardy , Auguste Deter , Alois Alzheimer , Liz Coulthard , Susan Kohlhaas , University College London , Alzheimer Research United Kingdom , Alzheimer Congress , Professor John Hardy , Research United Kingdom ,